<?xml version="1.0" encoding="UTF-8"?>
<p id="Par10">Common symptoms are fever, cough, and myalgia or fatigue [
 <xref ref-type="bibr" rid="CR40">40</xref>]. Less common symptoms were sputum production, headache, haemoptysis, and diarrhoea. About 55% of patients experienced dyspnea (median time from illness onset to dyspnoea was 8.0 days [IQR 5 · 0–13-1 · 0]) [
 <xref ref-type="bibr" rid="CR40">40</xref>]. Even some cases show loss of taste and smell [
 <xref ref-type="bibr" rid="CR17">17</xref>]. Approximately 25.5, 69.9, and 4.5% of patients were diagnosed with severe pneumonia, mild pneumonia, and non-pneumonia, respectively [
 <xref ref-type="bibr" rid="CR38">38</xref>]. Laboratory features of patients usually include leukopenia, lymphopenia and elevated aspartate aminotransferase. Compared with ICU patients, non-ICU patients had lower plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα [
 <xref ref-type="bibr" rid="CR14">14</xref>]. COVID-19 pneumonia baseline chest CT presented with ground glass opacities (72%), consolidation (13%), crazy paving pattern (12%), interlobular thickening (37%), adjacent pleura thickening (56%), and linear opacities combined (61%) [
 <xref ref-type="bibr" rid="CR41">41</xref>]. The COVID-19 deaths are more common in the majority of patients over 60 years age and suffer from underlying diseases such as hypertension, cardiovascular disease and cancer [
 <xref ref-type="bibr" rid="CR42">42</xref>].
</p>
